UBS O'Connor’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $711K | Sell |
14,548
-8,805
| -38% | -$430K | 0.04% | 230 |
|
|
2025
Q1 | $1.19M | Sell |
23,353
-23,541
| -50% | -$1.2M | 0.04% | 158 |
|
|
2024
Q4 | $2.12M | Buy |
46,894
+15,459
| +49% | +$698K | 0.06% | 148 |
|
|
2024
Q3 | $1.17M | Sell |
31,435
-1,565
| -5% | -$58.1K | 0.03% | 256 |
|
|
2024
Q2 | $1.01M | Buy |
33,000
+18,000
| +120% | +$550K | 0.03% | 291 |
|
|
2024
Q1 | $436K | Sell |
15,000
-21,052
| -58% | -$612K | 0.01% | 335 |
|
|
2023
Q4 | $994K | Sell |
36,052
-6,549
| -15% | -$180K | 0.03% | 266 |
|
|
2023
Q3 | $955K | Sell |
42,601
-2,500
| -6% | -$56K | 0.02% | 330 |
|
|
2023
Q2 | $1.83M | Sell |
45,101
-9,662
| -18% | -$393K | 0.04% | 313 |
|
|
2023
Q1 | $2.65M | Buy |
+54,763
| New | +$2.65M | 0.06% | 225 |
|
|
2015
Q4 | – | Sell |
-20,000
| Closed | -$534K | – | 483 |
|
|
2015
Q3 | $534K | Buy |
+20,000
| New | +$534K | 0.01% | 405 |
|